HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Di Simone, N. Articles by Caruso, A. Search for Related Content PubMed PubMed Citation Articles by Di Simone, N. Articles by Caruso, A.

Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Largo Gemelli 8, 00168 Rome, Italy
¹ Department of Microbiology, Catholic University of the Sacred Heart, Largo Gemelli 8, 00168 Rome, Italy

(Requests for offprints should be addressed to N Di Simone; Email: nicoletta.disimone{at}virgilio.it)

Resistin is a novel hormone that is secreted by human adipocytes and mononuclear cells and is probably associated with insulin resistance. Recently, resistin has been postulated to play a role in pregnancy, and resistin gene expression has been observed in placental tissues. However, it is still not known if resistin is able to affect trophoblast functions and development. Therefore, we investigated the hypothesis that resistin might regulate trophoblast production of matrix metalloproteinases (MMPs), the tissue inhibitors of metalloproteinases (TIMPs), trophoblast invasive behavior and the angiogenic processes.

In human choriocarcinoma cells (BeWo), resistin (10–100 ng/ml) enhanced both MMP-2 protein and mRNA expression, significantly reduced TIMP-1 and TIMP-2 and increased trophoblast-like cell invasiveness.

We analyzed the effect of resistin on an in vitro angiogenesis system for endothelial cells (HUVEC) and we evaluated its ability to modulate the secretion of an angiogenic factor, vascular endothelial growth factor (VEGF). Our data showed that resistin induced VEGF production and we observed that the addition of resistin stimulated endothelial cell tube formation.

These findings suggest that resistin might be able to induce BeWo cell invasiveness and to contribute to the control of placental vascular development.

This article has been cited by other articles:

				N. J. Hannan, P. Paiva, E. Dimitriadis, and L. A. Salamonsen Models for Study of Human Embryo Implantation: Choice of Cell Lines? Biol Reprod, February 1, 2010; 82(2): 235 - 245. [Abstract] [Full Text] [PDF]

				S. Ledoux, I. Queguiner, S. Msika, S. Calderari, P. Rufat, J.-M. Gasc, P. Corvol, and E. Larger Angiogenesis Associated With Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity Diabetes, December 1, 2008; 57(12): 3247 - 3257. [Abstract] [Full Text] [PDF]

				B. Pan, M.-H. Zhao, Z. Chen, L. Lu, Y. Wang, D.-W. Shi, and P.-Z. Han Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells Endocr. Relat. Cancer, December 1, 2007; 14(4): 1063 - 1071. [Abstract] [Full Text] [PDF]

				L.K. Harris, R.J. Keogh, M. Wareing, P.N. Baker, J.E. Cartwright, G.S. Whitley, and J.D. Aplin BeWo cells stimulate smooth muscle cell apoptosis and elastin breakdown in a model of spiral artery transformation Hum. Reprod., November 1, 2007; 22(11): 2834 - 2841. [Abstract] [Full Text] [PDF]